Editing Meatech

Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.

The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then publish the changes below to finish undoing the edit.

Latest revision Your text
Line 1: Line 1:
A meat revolution
== Summary ==


[[File:Meatech logo.jpg|150px|border=yes]]
{| class="wikitable"
|+ Key information
|-
| Risk/return|| Medium
|-
| Price per share|| $4.6
|-
| Asset class|| Equities
|-
| Industry|| Agritech
|-
| Country of incorporation|| United States
|-
| Minimum investment amount|| $4.6
|-
| Maximum investment amount|| $73 million
|-
| Current valuation|| $73 million
|-
| Investor type|| All
|-
| Tax schemes|| N/A
|-
| Bid/ask spread|| N/A
|-
| Commission amount|| N/A
|-
| Market|| Public
|}
== Summary<ref name=":0">Source: Edison Investment Research.</ref> ==
MeaTech 3D (MeaTech) is developing proprietary three-dimensional printing technology to be used in conjunction with its cultured meat process, which will enable the manufacture of premium meat products such as marbled steak. Alternative meat demand is booming and cellular agriculture could represent a new solution to the ever-increasing demand for protein. Cellular meat has the potential to significantly disrupt both meat- and non-meat markets over the next several decades.
MeaTech 3D (MeaTech) is developing proprietary three-dimensional printing technology to be used in conjunction with its cultured meat process, which will enable the manufacture of premium meat products such as marbled steak. Alternative meat demand is booming and cellular agriculture could represent a new solution to the ever-increasing demand for protein. Cellular meat has the potential to significantly disrupt both meat- and non-meat markets over the next several decades.
[[File:Meatech cover image.jpg]]


'''Meating demand'''
'''Meating demand'''
Line 50: Line 15:
Due to MeaTech’s start-up nature, financial forecasts cannot be made with any certainty and management does not expect to report positive revenues or profits in the short to medium term. Uncertainty is compounded by regulatory risk, as cultured meat is not yet approved in most jurisdictions. As MeaTech is the first listed cultured meat company, it has no direct peers. Its net cash position was $30.6m at end H121. Given the free cash flow burn was $5.9m during the period, assuming no further acceleration in cash burn would suggest the company has enough cash for the next c 2.5 years. That said, the trend has clearly been an acceleration in cash burn and the intent to start to design and set up a pilot scale cultured chicken fat facility in Belgium during FY22 is likely to cause cash burn to accelerate.
Due to MeaTech’s start-up nature, financial forecasts cannot be made with any certainty and management does not expect to report positive revenues or profits in the short to medium term. Uncertainty is compounded by regulatory risk, as cultured meat is not yet approved in most jurisdictions. As MeaTech is the first listed cultured meat company, it has no direct peers. Its net cash position was $30.6m at end H121. Given the free cash flow burn was $5.9m during the period, assuming no further acceleration in cash burn would suggest the company has enough cash for the next c 2.5 years. That said, the trend has clearly been an acceleration in cash burn and the intent to start to design and set up a pilot scale cultured chicken fat facility in Belgium during FY22 is likely to cause cash burn to accelerate.


== Cellular agriculture could disrupt protein production<ref name=":0" /> ==
== Cellular agriculture could disrupt protein production ==


Meat protein in particular has witnessed a sharp increase in demand over the last decade, due to increasing consumption predominantly in China and India, yet global supply has been disrupted at times by outbreaks of disease. More recently, however, consumers have developed an increasing awareness of the unsustainability of conventional meat, providing significant scope for alternatives. While plant-based meat is currently the only commercially available alternative priced at a level that is affordable for consumers (albeit at a premium to mass market meat), Edison Investment Research believes cultivated meat could become a much more desirable alternative to conventional meat, and indeed could potentially replace it as consumers embrace cultivated meat.
Meat protein in particular has witnessed a sharp increase in demand over the last decade, due to increasing consumption predominantly in China and India, yet global supply has been disrupted at times by outbreaks of disease. More recently, however, consumers have developed an increasing awareness of the unsustainability of conventional meat, providing significant scope for alternatives. While plant-based meat is currently the only commercially available alternative priced at a level that is affordable for consumers (albeit at a premium to mass market meat), we believe cultivated meat could become a much more desirable alternative to conventional meat, and indeed could potentially replace it as consumers embrace cultivated meat.


Kearney forecasts that the global meat market (including alternative meat) will grow from c US$1tn in 2018 to US$1.8tn by 2040. It forecasts that plant-based meat will grow significantly over the next 10 years as conventional meat sales decline, but cultivated meat is expected to overtake plant-based meat by 2040.
Kearney forecasts that the global meat market (including alternative meat) will grow from c US$1tn in 2018 to US$1.8tn by 2040. It forecasts that plant-based meat will grow significantly over the next 10 years as conventional meat sales decline, but cultivated meat is expected to overtake plant-based meat by 2040.
'''Exhibit 1: Growth of the total global meat market by type, 2018–40e'''
[[File:Growth of the total global meat market by type, 2018–40e.png|600px]]
Source: Kearney, Edison Investment Research


Protein consumption has witnessed a significant shift over the past five years, with the launch of plant-based meat alternatives such as Beyond Meat’s and Impossible Foods’ burgers. Meat alternatives have become more mainstream and acceptable to non-vegetarians, and the emergence of flexitarianism (to reduce – rather than eliminate – overall meat intake) has encouraged consumers to transition towards plant-based products. Indeed, protein consumption has become more flexible, as consumers make decisions based on ethical, environmental and health considerations. Food retailers and restaurants have adapted by offering more plant-based alternatives over time, with the latest addition being plant-based ‘Beyond Fried Chicken’ at KFC restaurants in January. The dairy segment has also been significantly disrupted by the advent of plant-based alternatives: what started as a transient fashion led to an increased uptake of plant-based dairy alternatives. This, in turn, led to increased availability of tasting and appealing alternatives, with consumers increasingly switching to what are perceived to be more ethical and healthier options.
Protein consumption has witnessed a significant shift over the past five years, with the launch of plant-based meat alternatives such as Beyond Meat’s and Impossible Foods’ burgers. Meat alternatives have become more mainstream and acceptable to non-vegetarians, and the emergence of flexitarianism (to reduce – rather than eliminate – overall meat intake) has encouraged consumers to transition towards plant-based products. Indeed, protein consumption has become more flexible, as consumers make decisions based on ethical, environmental and health considerations. Food retailers and restaurants have adapted by offering more plant-based alternatives over time, with the latest addition being plant-based ‘Beyond Fried Chicken’ at KFC restaurants in January. The dairy segment has also been significantly disrupted by the advent of plant-based alternatives: what started as a transient fashion led to an increased uptake of plant-based dairy alternatives. This, in turn, led to increased availability of tasting and appealing alternatives, with consumers increasingly switching to what are perceived to be more ethical and healthier options.


Edison Investment Research believes cultivated meat and seafood has the potential to disrupt conventional farming and fishing industries in a similar way. If the technical hurdles of cost, scalability and regulatory risk prove surmountable, cultivated protein could be priced at a similar level to conventional protein, but with much cleaner and more sustainable credentials.
We believe cultivated meat and seafood has the potential to disrupt conventional farming and fishing industries in a similar way. If the technical hurdles of cost, scalability and regulatory risk prove surmountable, cultivated protein could be priced at a similar level to conventional protein, but with much cleaner and more sustainable credentials.


== Cellular agriculture explained ==
== Cellular agriculture explained ==
Line 73: Line 32:


The typical time spent in the bioreactor depends on the species but is much shorter than conventional livestock farming: beef cells take c 30 days to mature compared to around 24 months via conventional farming, while chicken cells take one to two weeks compared to the usual 12–16 weeks. The key difference from plant-based proteins, which is likely to make cultivated meat much more attractive to consumers, is that cultivated meat is equivalent to normal meat at the molecular level, thus providing the same taste and nutritional profile as traditional meat.
The typical time spent in the bioreactor depends on the species but is much shorter than conventional livestock farming: beef cells take c 30 days to mature compared to around 24 months via conventional farming, while chicken cells take one to two weeks compared to the usual 12–16 weeks. The key difference from plant-based proteins, which is likely to make cultivated meat much more attractive to consumers, is that cultivated meat is equivalent to normal meat at the molecular level, thus providing the same taste and nutritional profile as traditional meat.
'''Exhibit 2: Cellular agriculture process'''
[[File:Cellular agriculture process.png|600px]]
Source: Edison Investment Research


=== Creating a structure via 3D bioprinting ===
=== Creating a structure via 3D bioprinting ===
Line 86: Line 39:
In December 2021, MeaTech 3D reported a breakthrough with the printing of a 3.67oz (104g) cultivated steak consisting of real, living muscle and fat tissues, without utilising any soy or pea protein. Management believes this is the largest cultivated steak produced to date. The company plans to have a demo facility for beef products within the next two to three years and to commence the design and potentially the building of a pilot plant for cultured chicken fat production in 2022.
In December 2021, MeaTech 3D reported a breakthrough with the printing of a 3.67oz (104g) cultivated steak consisting of real, living muscle and fat tissues, without utilising any soy or pea protein. Management believes this is the largest cultivated steak produced to date. The company plans to have a demo facility for beef products within the next two to three years and to commence the design and potentially the building of a pilot plant for cultured chicken fat production in 2022.


Edison Investment Research notes that MeaTech is also working on hybrid products, whereby cultured fat cells are added to plant-based protein to create meatier textures that are generally preferred by consumers.
We note MeaTech is also working on hybrid products, whereby cultured fat cells are added to plant-based protein to create meatier textures that are generally preferred by consumers.
 
'''Exhibit 3: MeaTech’s cultured steak vision'''
 
[[File:MeaTech’s cultured steak vision.png|600px]]
 
Source: MeaTech 3D.


=== Peace of Meat: The hybrid opportunity ===
=== Peace of Meat: The hybrid opportunity ===
Line 109: Line 56:


Conventional livestock farming is well-known for causing carbon emissions and for its use of land, water and energy. In contrast, cellular agriculture is much less resource-intensive. For example, each kilogram of conventional farmed meat produces on average 14kg of CO2 emissions, versus 3kg for cultured meat (source: MeaTech).
Conventional livestock farming is well-known for causing carbon emissions and for its use of land, water and energy. In contrast, cellular agriculture is much less resource-intensive. For example, each kilogram of conventional farmed meat produces on average 14kg of CO2 emissions, versus 3kg for cultured meat (source: MeaTech).
'''Exhibit 4: Resource use of conventionally farmed beef compared to cultured beef'''
[[File:Resource use of conventionally farmed beef compared to cultured beef.png|600px]]
Source: MeaTech 3D, Edison Investment Research


In addition, while conventional farming of livestock and fish uses most of the antibiotics produced worldwide, cellular agriculture requires minimal or no antibiotics. Food safety is also improved with cultured meat, due to the absence of mass slaughtering and the clean environment in which the cells are cultured. This reduces the likelihood of contamination from pathogens such as salmonella or E. coli and also results in the benefit of a longer shelf life for the finished product.
In addition, while conventional farming of livestock and fish uses most of the antibiotics produced worldwide, cellular agriculture requires minimal or no antibiotics. Food safety is also improved with cultured meat, due to the absence of mass slaughtering and the clean environment in which the cells are cultured. This reduces the likelihood of contamination from pathogens such as salmonella or E. coli and also results in the benefit of a longer shelf life for the finished product.
Line 134: Line 75:
The much-touted number in the alternative protein industry is the cost of the first cultivated meat burger, which is placed at around €250,000 (it was developed by a Dutch scientist in 2013, although the CEO of Mosa Meat has subsequently stated that the real number is ‘a bit higher’). The cost has come down significantly but, for the product to become a viable alternative to conventional meat, something in the region of cost parity is required. As Nick Halla, senior VP International at Impossible Foods, has said, ‘you’ll buy the product once based on novelty, you’ll come back if the taste is good and if there are benefits such as nutrition and sustainability, and you’ll buy it in the long run if the value is right.’
The much-touted number in the alternative protein industry is the cost of the first cultivated meat burger, which is placed at around €250,000 (it was developed by a Dutch scientist in 2013, although the CEO of Mosa Meat has subsequently stated that the real number is ‘a bit higher’). The cost has come down significantly but, for the product to become a viable alternative to conventional meat, something in the region of cost parity is required. As Nick Halla, senior VP International at Impossible Foods, has said, ‘you’ll buy the product once based on novelty, you’ll come back if the taste is good and if there are benefits such as nutrition and sustainability, and you’ll buy it in the long run if the value is right.’


The other side of the equation in terms of achieving anything close to price parity is the cost of conventional meat. Edison Investment Research notes that COVID-19 has driven up prices as the meat industry in many regions has suffered from labour shortages and increased freight costs. As concerns regarding climate change and sustainability come to the fore, Edison Investment Research could see governments start to reduce some farming subsidies or indeed introduce some form of taxation on carbon emissions caused by farming. This would cause cost increases for conventionally farmed produce.
The other side of the equation in terms of achieving anything close to price parity is the cost of conventional meat. We note that COVID-19 has driven up prices as the meat industry in many regions has suffered from labour shortages and increased freight costs. As concerns regarding climate change and sustainability come to the fore, we could see governments start to reduce some farming subsidies or indeed introduce some form of taxation on carbon emissions caused by farming. This would cause cost increases for conventionally farmed produce.


'''Regulation'''
'''Regulation'''


As discussed above, cultivated meat is not currently approved for sale in any jurisdiction apart from Singapore. That said, as cellular agriculture becomes closer to commercial viability, Edison Investment Research would expect more regulators to examine and approve the product. Edison Investment Research notes that regulation changes by jurisdiction, but also by product: for example, cultivated seafood would only require approval by the FDA in the United States, while cultivated meat requires both FDA and USDA approval in the United States. Edison Investment Research notes that in the EU, approval would be required both by the European Food Safety Authority via the Novel Food Regulation and individual countries. Furthermore, approval will be required for each different product and, potentially, using different components (such as edible scaffolds) would require a new safety review each time. Farming lobbies are powerful worldwide, especially in the United States and the EU. Edison Investment Research would expect farmers to lobby aggressively against the approval of cellular agriculture, and potentially try and dissuade consumers from switching to cultivated food.
As discussed above, cultivated meat is not currently approved for sale in any jurisdiction apart from Singapore. That said, as cellular agriculture becomes closer to commercial viability, we would expect more regulators to examine and approve the product. We note that regulation changes by jurisdiction, but also by product: for example, cultivated seafood would only require approval by the FDA in the United States, while cultivated meat requires both FDA and USDA approval in the United States. We note that in the EU, approval would be required both by the European Food Safety Authority via the Novel Food Regulation and individual countries. Furthermore, approval will be required for each different product and, potentially, using different components (such as edible scaffolds) would require a new safety review each time. Farming lobbies are powerful worldwide, especially in the United States and the EU. We would expect farmers to lobby aggressively against the approval of cellular agriculture, and potentially try and dissuade consumers from switching to cultivated food.
 
==MeaTech’s vision: A B2B service<ref name=":0" />==
 
MeaTech is targeting a broad range of cell types and cultured products, through both research and development (R&D) and acquisitions. While MeaTech began its R&D with beef cultured products, it acquired Peace of Meat in February 2020, as previously mentioned, which focuses on avian products. In July 2021, MeaTech announced it was launching development of cultivated pork cells. MeaTech’s development of fat and muscle cells for each class of meat is aimed at eventually developing hybrid products (which, as a reminder, contain a mix of plant-based and cultured meat), ground meat products, processed meat and structured 3D printed meat. Edison Investment Research illustrates this in Exhibit 5.
 
'''Exhibit 5: Cultured products targeted by MeaTech'''


[[File:Cultured products targeted by MeaTech.png|600px]]
==MeaTech’s vision: A B2B service==


Source: MeaTech 3D
MeaTech is targeting a broad range of cell types and cultured products, through both research and development (R&D) and acquisitions. While MeaTech began its R&D with beef cultured products, it acquired Peace of Meat in February 2020, as previously mentioned, which focuses on avian products. In July 2021, MeaTech announced it was launching development of cultivated pork cells. MeaTech’s development of fat and muscle cells for each class of meat is aimed at eventually developing hybrid products (which, as a reminder, contain a mix of plant-based and cultured meat), ground meat products, processed meat and structured 3D printed meat. We illustrate this in Exhibit 5.


MeaTech’s current focus is on developing its proprietary 3D printing technology and cell culturing processes and building a demo facility. As previously mentioned, MeaTech has nine patents pending covering key aspects of both the cell culturing and 3D printing process. In the longer term, MeaTech intends to out-license its technology to interested food manufacturers or retailers. The business model will be to obtain revenue streams both from licensing the process and from support services. The latter will encompass engineering services in terms of helping to operate the plants and the technology, food technology services to help optimise the finished product, but also the supply of cell lines and scaffolding materials.
MeaTech’s current focus is on developing its proprietary 3D printing technology and cell culturing processes and building a demo facility. As previously mentioned, MeaTech has nine patents pending covering key aspects of both the cell culturing and 3D printing process. In the longer term, MeaTech intends to out-license its technology to interested food manufacturers or retailers. The business model will be to obtain revenue streams both from licensing the process and from support services. The latter will encompass engineering services in terms of helping to operate the plants and the technology, food technology services to help optimise the finished product, but also the supply of cell lines and scaffolding materials.


Edison Investment Research believes MeaTech could out-license its technology to different customers (food manufacturers and/or retailers) in different regions, probably giving either product or geographical exclusivity to each customer.
We believe MeaTech could out-license its technology to different customers (food manufacturers and/or retailers) in different regions, probably giving either product or geographical exclusivity to each customer.
 
'''Exhibit 6: MeaTech future revenue stream model'''
 
[[File:MeaTech future revenue stream model.png|600px]]
 
Source: MeaTech 3D


In terms of geography, MeaTech is based in Israel but also has operations in Belgium, at its subsidiary, POM. In March 2022, MeaTech announced it was expanding its operation into the US to accelerate its go-to-market strategy. Its California-based office will include activities in R&D, business development and investor relations. It has recently moved into new headquarters in Rehovot (Israel), which is the epicentre of Israel’s foodtech sector.
In terms of geography, MeaTech is based in Israel but also has operations in Belgium, at its subsidiary, POM. In March 2022, MeaTech announced it was expanding its operation into the US to accelerate its go-to-market strategy. Its California-based office will include activities in R&D, business development and investor relations. It has recently moved into new headquarters in Rehovot (Israel), which is the epicentre of Israel’s foodtech sector.


==Management<ref name=":0" />==
==Management==


The senior leadership team at MeaTech comprises:
The senior leadership team at MeaTech comprises:
Line 176: Line 105:
'''Simon Fried, Head of Business''': Simon has broad experience covering tech, retail, fast-moving consumer goods, finance and strategy consulting. Before joining MeaTech in December 2019, he was co-founder of CBO and US president of Nano Dimension.
'''Simon Fried, Head of Business''': Simon has broad experience covering tech, retail, fast-moving consumer goods, finance and strategy consulting. Before joining MeaTech in December 2019, he was co-founder of CBO and US president of Nano Dimension.


==Financials<ref name=":0" />==
==Financials==


MeaTech is still in its early stages and hence does not have any revenues, nor is it expecting to have any in the shorter term.
MeaTech is still in its early stages and hence does not have any revenues, nor is it expecting to have any in the shorter term.


Edison Investment Research provides summary financials below.
We provide summary financials below.
 
{| class="wikitable"
|+ Exhibit 7: Summary P&L
|-
! Year ending December ($ 000) !! 2019 !! 2020 !! H12021
|-
| R&D expenses|| (166) || (2,491) || (2,146)
|-
| Marketing expenses || 0|| (506)|| (600)
|-
| General and administrative expenses || (256)|| (5,380)|| (3,983)
|-
| Public listing expenses|| 0|| (10,164)|| 0
|-
| Operating profit/(loss)|| (422)|| (18,541)|| (6,729)
|-
| Net financing income/(expense) || (1) || 17|| (89)
|-
| Net profit/(loss)|| (423) || (18,524)|| (6,818)
|-
| colspan="4" | '''Source: MeaTech 3D'''
|}
 
R&D expenses were $2.5m in FY20 and $2.1m in H121, reflecting MeaTech’s increased investment to expand its cultured meat technology capabilities. Operating losses in FY20 were affected by listing expenses. Edison Investment Research believes the cash flow statement is more relevant, given MeaTech is an early stage company. Free cash flow is obviously negative as the company is loss-making. Free cash flow burn has been accelerating as MeaTech has stepped up its investments to expand its capabilities.
 
For completeness, Edison Investment Research also provides a summary balance sheet.
 
{| class="wikitable"
|+ Exhibit 8: Summary balance sheet
|-
! Year ending December ($ 000) !! 2019 !! 2020 !! H121
|-
| Cash & cash equivalents|| 975|| 9,043|| 24,782
|-
| Other|| 309|| 149|| 147
|-
| Receivables|| 38|| 131|| 1,174
|-
| Total current assets || 1,322|| 9,323|| 26,103
|-
| Net fixed assets || 127|| 906|| 2,206
|-
| Intangible assets || 0|| 0|| 9,930
|-
| Other assets || 239|| 2,732|| 1,958
|-
| Total non-current assets || 366|| 3,638|| 14,094
|-
| Payables || 295|| 1,347|| 1,932
|-
| Other || 109|| 496|| 210
|-
| Total current liabilities || 404|| 1,843|| 2,142
|-
| Long-term lease liabilities|| 92|| 0|| 102
|-
| Total non-current liabilities || 92|| 0|| 102
|-
| Total net assets || 1,491|| 15,631|| 43,808
|-
| colspan=4 | '''Source: MeaTech 3D'''
|}
 
 
{| class="wikitable"
|+ Exhibit 9: Summary cash flow statement
|-
! Year ending December ($ 000) !! 2019 !! 2020 !! H121
|-
| Net profit/(loss) || (423)|| (18,524)|| (6,818)
|-
| Depreciation & amortisation || 21|| 213|| 278
|-
| change in fair value of derivatives & other investments || 0|| (110)|| (401)
|-
| Share-based payments || 0|| 3,958|| 2,313
|-
| Public listing expenses || 0|| 10,164|| 0
|-
| Change in receivables || (36)|| 5|| (782)
|-
| Change in payables || 251|| 462|| 457
|-
| Other || 14|| 0|| 0
|-
| Net cash from operating activities || (173)|| (3,832) || (4,953)
|-
| Purchase of fixed assets || (126)|| (681)|| (902)
|-
| Free cash flow || (299)|| (4,513)|| (5,855)
|-
| Change in restricted deposit || (41)|| (6)||(337)
|-
| Acquisitions || 0|| (1,188)|| (4,848)
|-
| Other|| (86)|| 0|| 0
|-
| Net cash from investing activities|| (253)|| (1,875)|| (6,087)
|-
| Proceeds from issuance of shares & warrants|| 1,670|| 14,887|| 27,143
|-
| Issuance costs|| (8)|| (819)|| (1,145)
|-
| Repayment of lease liability || (14)|| (140)|| (134)
|-
| Proceeds from exercise of share options || 0|| 2,776|| 3,196
|-
| Proceeds from other financing activities || 0|| 641|| 73
|-
| Net cash from financing activities ||1,648||17,345||29,133
|-
| Increase in cash & cash equivalents||1,222||11,638||18,093
|-
| FX|| 21||644||(1,012)
|-
| Cash & cash equivalents at start of the period ||31|| 1,274|| 13,556
|-
| Cash & cash equivalents at end of the period || 1,274|| 13,556|| 30,637
|-
| colspan=4 | '''Source: MeaTech 3D'''
|}


==Valuation<ref name=":0" />==
R&D expenses were $2.5m in FY20 and $2.1m in H121, reflecting MeaTech’s increased investment to expand its cultured meat technology capabilities. Operating losses in FY20 were affected by listing expenses. We believe the cash flow statement is more relevant, given MeaTech is an early stage company. Free cash flow is obviously negative as the company is loss-making. Free cash flow burn has been accelerating as MeaTech has stepped up its investments to expand its capabilities.


MeaTech is still in its early stages, hence without revenues or profits expected in the shorter term, it is hard to value. Furthermore, as MeaTech is the first listed cultured meat company, it has no direct peers. The closest listed peers are in the alternative protein segment, namely Beyond Meat, Oatly and Burcon Nutrascience. While none of these are expected to be profitable in the shorter term, MeaTech’s peers do generate revenues at present. Edison Investment Research notes that both Beyond Meat and Oatly have recently reduced their expectations for FY22 due to slower growth/consumer uptake and rising raw material costs. Based on consensus, Oatly is trading on a FY22e EV/sales multiple of c 3.0x and Beyond Meat is trading on c 5.5x. In Edison Investment Research's view, it would therefore not be unreasonable to assume that MeaTech could achieve a similar low-to-mid single-digit multiple once there is a track record of a few years of strong revenue growth.
For completeness we also provide a summary balance sheet.


More meaningfully, Edison Investment Research notes that MeaTech’s net cash position was $30.6m at end H121. Given the free cash flow burn was $5.9m during the period, assuming no further acceleration in cash burn would suggest the company has enough cash for the next c 2.5 years. That said, the trend has clearly been an acceleration in cash burn, and the company’s plan to start the design of a pilot scale cultured chicken fat facility in Belgium during FY22 is likely to cause cash burn to accelerate further.
==Valuation==


{| class="wikitable"
MeaTech is still in its early stages, hence without revenues or profits expected in the shorter term, it is hard to value. Furthermore, as MeaTech is the first listed cultured meat company, it has no direct peers. The closest listed peers are in the alternative protein segment, namely Beyond Meat, Oatly and Burcon Nutrascience. While none of these are expected to be profitable in the shorter term, MeaTech’s peers do generate revenues at present. We note both Beyond Meat and Oatly have recently reduced their expectations for FY22 due to slower growth/consumer uptake and rising raw material costs. Based on consensus, Oatly is trading on a FY22e EV/sales multiple of c 3.0x and Beyond Meat is trading on c 5.5x. In our view, it would therefore not be unreasonable to assume that MeaTech could achieve a similar low-to-mid single-digit multiple once there is a track record of a few years of strong revenue growth.
|+ Exhibit 10: Peer valuation
|-
!  !! Market cap (m) !! EV (m) !! EV/Sales (x) - 2021a !! EV/Sales (x) - 2022e !! EV/EBITDA (x) - 2021a !! EV/EBITDA (x) - 2022e
|-
| Oatly|| $3,178|| $2,782|| 4.4|| 3.0|| (21.6)|| (21.2)
|-
| Beyond Meat|| $2,702 || $3,099|| 6.7|| 5.3|| (36.1)|| (24.1)
|-
| Burcon Nutrascience || C$114 || C$105|| 1047.9|| 588.7|| (30.5)|| (23.6)
|-
| Peer group average || || || 353.0 || 199.0 || (29.4)|| (23.0)
|-
| MeaTech || US$83


|| US$52|| N/A|| N/A || N/A|| N/A
More meaningfully, we note MeaTech’s net cash position was $30.6m at end H121. Given the free cash flow burn was $5.9m during the period, assuming no further acceleration in cash burn would suggest the company has enough cash for the next c 2.5 years. That said, the trend has clearly been an acceleration in cash burn, and the company’s plan to start the design of a pilot scale cultured chicken fat facility in Belgium during FY22 is likely to cause cash burn to accelerate further.
|-
| colspan=7 | Source: Refinitiv, Edison Investment Research. Note: Priced at 10 March 2022.  
|}


==Sensitivities==
==Sensitivities==
Line 340: Line 132:
* Economic outlook: despite cellular meat having strong long-term growth drivers from demographic changes and consumer demand for more sustainable food sources, the demand for meat (both conventional and alternative) is vulnerable to changes in the macroeconomic outlook and consumer incomes. This is especially likely to be the case in the nearer term, as cellular meat is likely to be sold at a premium when launched initially.
* Economic outlook: despite cellular meat having strong long-term growth drivers from demographic changes and consumer demand for more sustainable food sources, the demand for meat (both conventional and alternative) is vulnerable to changes in the macroeconomic outlook and consumer incomes. This is especially likely to be the case in the nearer term, as cellular meat is likely to be sold at a premium when launched initially.
* Changing consumer preferences: MeaTech may be exposed to changes in consumer tastes and preferences, with consumers choosing to shun cultured meat products.
* Changing consumer preferences: MeaTech may be exposed to changes in consumer tastes and preferences, with consumers choosing to shun cultured meat products.
==Actions==
To invest in Meatech, click [https://www.plus500.com/en/ here]
To contact Meatech, click [mailto:info@meatech3d.com here].
== References and notes ==
[[Category:Thesis]]
[[Category:Equities]]
__INDEX__
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see Stockhub:Copyrights for details). Do not submit copyrighted work without permission!
Cancel Editing help (opens in new window)